Shanghai Junshi Biosciences Co., Ltd. (01877) announced its preliminary results for the year of 2020.
Its net loss attributable to owners of the parent company was RMB1.67 billion, compared to the loss of RMB747.42 million of the same period last year. The basic loss per share was RMB2.04.
The total operating income was RMB1.59 billion, a year-on-year increase of 105.77%.
全新節目《說說心理話》青少年不可以戀愛!?真實個案講述驚心動魄經歷► 即睇